查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫院感染控制市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按最終用戶、按地區
市場調查報告書
商品編碼
1398752

全球醫院感染控制市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按最終用戶、按地區

Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 201 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球醫院感染控制市場經歷了顯著成長，預計2024年全球銷售額將達到68億美元，到2031年底將達到96億美元。

過去十年，由於先進醫療技術的引入，醫療保健環境發生了重大變化。 隨著傳染病和慢性病的盛行率迅速增加，消毒滅菌設備的需求空前巨大。

大眾對醫療保健相關感染的認識不斷提高，對感染控制措施的需求也越來越大。 旨在加強醫療機構感染控制系統的政府計劃在市場擴張中發揮至關重要的作用。 傳染病的日益普及正在推動對感染控制技術的需求。 此次疫情凸顯了醫療環境中感染控制的重要性，導致相關設備的需求增加。

本報告調查了全球醫院感染控制市場，並概述了市場概況、按產品、最終用戶、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章 2018-2031 年全球醫院感染控制市場展望

  • 2018-2031 年全球醫院感染控制市場前景，依產品、價值（十億美元）、數量（百萬單位）
  • 2018-2031 年全球醫院感染控制市場前景（按最終用戶劃分）、價值（十億美元）、數量（百萬單位）
  • 2018-2031 年全球醫院感染控制市場前景（按地區、價值（十億美元）、數量（百萬台））

第 4 章 2018-2031 年北美醫院感染控制市場展望

第五章歐洲醫院感染控制市場展望，2018-2031

第 6 章亞太地區醫院感染控制市場展望，2018-2031

第 7 章拉丁美洲醫院感染控制市場前景，2018-2031

第 8 章 2018-2031 年中東和非洲醫院感染控制市場展望

第九章競爭態勢

  • 產品和最終用戶熱圖
  • 製造商和最終用戶的熱圖
  • 2023 年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Olympus Corporation
    • Medivators Inc. (Cantel Medical Corp.)
    • Getinge Group
    • STERIS Plc.
    • Belimed AG (Metall Zug)
    • Steelco S.P.A.
    • Pfizer Inc.,
    • F. Hoffmann-La Roche Ltd,
    • Merck & Co.,
    • Advanced Sterilization Products Services Inc.
    • Abbott Laboratories
    • Bayer AG
    • The 3M Company
    • Cepheid Inc.
    • UVision360 Inc.

第 10 章附錄

簡介目錄

The Hospital Acquired Infection Control Market is poised for substantial growth, with worldwide revenue reaching US$ 6.8 Billion in 2024 and anticipated to propel the market to US$ 9.6 Billion by the end of 2031, according to the latest report by Fairfield Market Research.

Changing Healthcare Infrastructure and the Demand for Infection Control

Over the past decade, the healthcare landscape has undergone significant transformations, marked by the adoption of advanced medical technologies. As the prevalence of infectious and chronic diseases has surged, the need for disinfection and sterilization equipment has never been more critical.

Driving Factors for Hospital Acquired Infection Control Market Expansion

Several factors are contributing to the growing demand for hospital-acquired infection control technology:

  • Rising Public Awareness: Increasing awareness about healthcare-associated infections among the public is driving the need for infection control measures.
  • Government Initiatives: Government programs aimed at strengthening infection control systems in medical facilities are playing a pivotal role in market expansion.
  • Prevalence of Infectious Diseases: The rising incidence of infectious and communicable diseases is fueling the demand for infection control technology.
  • Impact of COVID-19: The pandemic underscored the importance of infection control in healthcare settings, leading to increased demand for related equipment.

Manufacturers Expanding Their Markets

Manufacturers in the hospital acquired infection control market are expanding their reach through various strategies:

  • Increased awareness about personal hygiene is driving the demand for sterilized medical equipment, especially as the number of surgical procedures rises.
  • The demand for nosocomial infection control equipment is growing as people recognize the benefits of sterilization.
  • Minimally invasive procedures and the rise of outpatient services are contributing to market growth.
  • Increasing government initiatives and growing public awareness are expanding the number of outpatients, further driving market progress.

Challenges in Market Progress

While the hospital acquired infection control market holds immense potential, challenges exist:

  • The complexity of infection control methods and the need for advanced technologies can be obstacles.
  • Reprocessing technology for medical devices poses challenges in ensuring their safety for reuse, affecting market expansion to some extent.

Booming Market in the United States

The United States presents a highly lucrative market for hospital-acquired infection control equipment due to its advanced healthcare system, high healthcare costs, and widespread public awareness of infection control issues. It is expected to generate a significant share of the region's revenue.

Emerging Market in China

China is emerging as a prominent market for hospital-acquired infection control, driven by increasing public awareness of hospital-acquired infections, government support programs, and a rising number of such infections. China is expected to dominate in terms of revenue share.

Focus on India

India, as the second-most populous country in the world, offers substantial potential for hospital-acquired infection control equipment suppliers. As hygiene awareness and attention to healthcare intensify, India is likely to experience significant growth in demand for disinfection equipment. The nation's healthcare infrastructure is expected to advance rapidly over the next decade, presenting opportunities for local market players.

Competitive Landscape

The healthcare-associated infections segment has gained significant attention, prompting key industry players to invest in research and development and launch new products. Some key companies profiled in the hospital acquired infection control market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Market Segmentation

By Product :

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
  • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
  • Endoscopic Reprocessor Systems
    • Single Basin Endoscopic Reprocessor Systems
    • Dual Basin Endoscopic Reprocessor Systems
  • Disinfectants

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hospital Acquired Infection Control Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Heat Sterilization Equipment
        • 3.1.1.1.1. Moist Heat Sterilization Equipment
        • 3.1.1.1.2. Dry Heat Sterilization Equipment
      • 3.1.1.2. Low-Temperature Sterilization Equipment
      • 3.1.1.3. Radiation Sterilization Equipment
      • 3.1.1.4. Disinfection Equipment
        • 3.1.1.4.1. Disinfector
          • 3.1.1.4.1.1. Disinfector
            • 3.1.1.4.1.1.1. Washer Disinfector
            • 3.1.1.4.1.1.2. Flusher Disinfector
        • 3.1.1.4.2. Flusher Disinfector
      • 3.1.1.5. Endoscopic Reprocessor Systems
        • 3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 3.1.1.6. Disinfectants
  • 3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical Centres
      • 3.2.1.3. Medical Institutions
      • 3.2.1.4. Diagnostic Laboratories
      • 3.2.1.5. Clinics
  • 3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Heat Sterilization Equipment
        • 4.1.1.1.1. Moist Heat Sterilization Equipment
        • 4.1.1.1.2. Dry Heat Sterilization Equipment
      • 4.1.1.2. Low-Temperature Sterilization Equipment
      • 4.1.1.3. Radiation Sterilization Equipment
      • 4.1.1.4. Disinfection Equipment
        • 4.1.1.4.1. Disinfector
          • 4.1.1.4.1.1. Disinfector
            • 4.1.1.4.1.1.1. Washer Disinfector
            • 4.1.1.4.1.1.2. Flusher Disinfector
        • 4.1.1.4.2. Flusher Disinfector
      • 4.1.1.5. Endoscopic Reprocessor Systems
        • 4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 4.1.1.6. Disinfectants
  • 4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ambulatory Surgical Centres
      • 4.2.1.3. Medical Institutions
      • 4.2.1.4. Diagnostic Laboratories
      • 4.2.1.5. Clinics
  • 4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Heat Sterilization Equipment
        • 5.1.1.1.1. Moist Heat Sterilization Equipment
        • 5.1.1.1.2. Dry Heat Sterilization Equipment
      • 5.1.1.2. Low-Temperature Sterilization Equipment
      • 5.1.1.3. Radiation Sterilization Equipment
      • 5.1.1.4. Disinfection Equipment
        • 5.1.1.4.1. Disinfector
          • 5.1.1.4.1.1. Disinfector
            • 5.1.1.4.1.1.1. Washer Disinfector
            • 5.1.1.4.1.1.2. Flusher Disinfector
        • 5.1.1.4.2. Flusher Disinfector
      • 5.1.1.5. Endoscopic Reprocessor Systems
        • 5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 5.1.1.6. Disinfectants
  • 5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ambulatory Surgical Centres
      • 5.2.1.3. Medical Institutions
      • 5.2.1.4. Diagnostic Laboratories
      • 5.2.1.5. Clinics
  • 5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Heat Sterilization Equipment
        • 6.1.1.1.1. Moist Heat Sterilization Equipment
        • 6.1.1.1.2. Dry Heat Sterilization Equipment
      • 6.1.1.2. Low-Temperature Sterilization Equipment
      • 6.1.1.3. Radiation Sterilization Equipment
      • 6.1.1.4. Disinfection Equipment
        • 6.1.1.4.1. Disinfector
          • 6.1.1.4.1.1. Disinfector
            • 6.1.1.4.1.1.1. Washer Disinfector
            • 6.1.1.4.1.1.2. Flusher Disinfector
        • 6.1.1.4.2. Flusher Disinfector
      • 6.1.1.5. Endoscopic Reprocessor Systems
        • 6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 6.1.1.6. Disinfectants
  • 6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ambulatory Surgical Centres
      • 6.2.1.3. Medical Institutions
      • 6.2.1.4. Diagnostic Laboratories
      • 6.2.1.5. Clinics
  • 6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Heat Sterilization Equipment
        • 7.1.1.1.1. Moist Heat Sterilization Equipment
        • 7.1.1.1.2. Dry Heat Sterilization Equipment
      • 7.1.1.2. Low-Temperature Sterilization Equipment
      • 7.1.1.3. Radiation Sterilization Equipment
      • 7.1.1.4. Disinfection Equipment
        • 7.1.1.4.1. Disinfector
          • 7.1.1.4.1.1. Disinfector
            • 7.1.1.4.1.1.1. Washer Disinfector
            • 7.1.1.4.1.1.2. Flusher Disinfector
        • 7.1.1.4.2. Flusher Disinfector
      • 7.1.1.5. Endoscopic Reprocessor Systems
        • 7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 7.1.1.6. Disinfectants
  • 7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ambulatory Surgical Centres
      • 7.2.1.3. Medical Institutions
      • 7.2.1.4. Diagnostic Laboratories
      • 7.2.1.5. Clinics
  • 7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Heat Sterilization Equipment
        • 8.1.1.1.1. Moist Heat Sterilization Equipment
        • 8.1.1.1.2. Dry Heat Sterilization Equipment
      • 8.1.1.2. Low-Temperature Sterilization Equipment
      • 8.1.1.3. Radiation Sterilization Equipment
      • 8.1.1.4. Disinfection Equipment
        • 8.1.1.4.1. Disinfector
          • 8.1.1.4.1.1. Disinfector
            • 8.1.1.4.1.1.1. Washer Disinfector
            • 8.1.1.4.1.1.2. Flusher Disinfector
        • 8.1.1.4.2. Flusher Disinfector
      • 8.1.1.5. Endoscopic Reprocessor Systems
        • 8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 8.1.1.6. Disinfectants
  • 8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ambulatory Surgical Centres
      • 8.2.1.3. Medical Institutions
      • 8.2.1.4. Diagnostic Laboratories
      • 8.2.1.5. Clinics
  • 8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Olympus Corporation
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Medivators Inc. (Cantel Medical Corp.)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Getinge Group
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. STERIS Plc.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Belimed AG (Metall Zug)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Steelco S.P.A.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Pfizer Inc.,
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. F. Hoffmann-La Roche Ltd,
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Merck & Co.,
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Abbott Laboratories
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bayer AG
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. The 3M Company
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Cepheid Inc.
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. UVision360 Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations